Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Precise drug delivery to tumors is crucial for effective cancer therapy.
• Nanosized drugs face challenges like toxicity and immunogenicity, hindering clinical use.
• Exosomes and nanoparticles offer potential for targeted drug delivery.

Purpose of the Study:

• To develop a novel cocktail therapy strategy for tumor-targeted treatment.
• To combine natural killer cell-derived exosomes (NKEXOs) with biomimetic core-shell nanoparticles (NNs).
• To evaluate the efficacy of this NN/NKEXO cocktail for neuroblastoma therapy.

Main Methods:

• Fabrication of core-shell nanoparticles (NNs) with a dendrimer core loading therapeutic miRNA and an NKEXO shell.
• Confirmation of NN/NKEXO fabrication using transmission electron microscopy (TEM) and confocal laser scanning microscopy (CLSM).
• In vivo evaluation of targeting and miRNA delivery in neuroblastoma using two-photon excited scanning fluorescence imaging (TPEFI) and IVIS Spectrum.

Main Results:

• Successful fabrication and characterization of the NN/NKEXO cocktail.
• Demonstrated highly efficient targeting and therapeutic miRNA delivery to neuroblastoma cells in vivo.
• Observed dual inhibition of tumor growth, highlighting therapeutic efficacy.

Conclusions:

• The NN/NKEXO cocktail represents a novel and biocompatible approach for tumor-targeted therapy.
• This strategy shows significant potential for clinical applications in cancer treatment.
• The combination therapy offers a promising new avenue for overcoming challenges in nanomedicine for cancer.